If you choose to no longer receive our free newsletter and daily market updates, click here to UNSUBSCRIBE
|
Welcome back Trendsters! Those dips aren't anything to get worked up about. It's more like a prime opportunity – a chance for us to spot some seriously undervalued gems. Don't let those price swings fool you. The smart move isn't to panic, it's to get strategic. Today, we're taking a closer look at why those market dips might actually be screaming "buy". We'll also get into AMD's bullish technical signals – perfect for our Chart of the Day analysis.
And of course, you know we always like to bring a little extra something to the table. Expect some market-moving news and maybe a sprinkle of fun trivia to spice up your trading day. So, hold on tight and get ready. It's time to turn those market moves into opportunities! |
|
|
There are plenty of reasons why this growing biotech company should be on your watchlist including an $18.70 price target! |
The biotech space is anticipated for a big rebound this year and one company that looks well-positioned to stand out is BioStem Technologies, Inc. (OTCQB: BSEM). In the last year, the company’s share price has moved from around $1 to over $9.
It’s evident that Wall Street is paying attention to this biotech company’s game-changing offerings for the global wound care market. The company is making waves for its focus on harnessing elements of perinatal tissue derived from the human placenta for manufacturing structural tissue allografts to heal wounds. The market for improved wound care products is growing exponentially. In terms of revenue, the global wound care market in terms of revenue was estimated to be worth $20.8 billion in 2022 and is poised to reach $27.2 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027.
It wasn’t that long ago that Zack’s Small Cap Research had increased its price target on the stock given the explosive Q3 earnings that were reported and recently reiterated that the company may be undervalued! Zack’s has increased its price target on BioStem Technologies, Inc. (OTCQB: BSEM) to $18.70! The price increase comes shortly after the company released some preliminary and unaudited numbers that showed net revenue for 4Q2023 of $11.5 million, well ahead of Zack’s estimates and a more than 1300% increase from the year ago period! For the year, the company also showed preliminary net revenue of $16.7 million, which would be more than a 140% increase over 2022. The official release and the full financials, according to the company, will be released in March.
See how the evidence is pointing to BioStem being one of the most exciting biotech companies underfollowed on Wall Street!
**Note: we have been compensated for this advertisement
|
|
|
Mixed Signals and the Search for Direction |
The market gave us a true dance this week – some flashy moves, but where's it ultimately headed? Mixed earnings reports and reminders from the Fed that we're not quite out of the inflationary woods seemed to create two camps: those rushing to buy on any dip and those opting to sit this one out. Here's where the major benchmarks ended: - The S&P 500® index (SPX) declined 10.41 points (0.2%) to 5,051.41, its lowest close in almost two months; the Dow Jones Industrial Average® ($DJI) advanced 63.86 points (0.2%) to 37,798.97; the Nasdaq Composite® ($COMP) eased 19.77 points (0.1%) to 15,865.25.
- The 10-year Treasury note yield gained almost 4 basis points to 4.667%.
- The CboeVolatility Index® (VIX) fell 0.83 to 18.40.
Big banks like Bank of America showed that even with rate hikes, net interest income can still take a hit. On the flip side, UnitedHealth Group soared on better-than-expected earnings. So, a question for Trendsters: is this a sign of sector-specific troubles, or simply the price of adjusting to a new interest rate reality?
Speaking of that reality... Bond yields are back on the climb, with the 10-year Treasury note flirting with 4.70%. Remember, rising yields often put pressure on stocks.
So, what now? The market's bullish start to the year may be facing a new test. We seem to be past the 'rip-roaring rally fueled by Fed pivot hopes' phase. Instead, it's time to carefully consider if the current landscape supports those early-year gains. Strategies for Trendsters: -
Play the long game: Rate hikes take time to fully ripple through the economy. A 'buy the dip' mentality might not yield a quick return.
- Watch earnings closely: They'll continue to reveal the true impact of higher rates and inflation on company bottom lines.
- Don't forget diversification: A mixed market landscape calls for a balanced portfolio to manage volatility.
|
|
|
This might be the most amazing financial education collaboration we have ever pulled off. 11 of the most well-known gurus and educators in the market come together for….. -
PDF: Get your own copy of “Unlocking Profits” with a chapter dedicated to transforming your portfolio overnight: Learn the Secret to Doubling Your Trading Account
-
Special Bonus: When you register for free today you get 2 special bonuses from our friends at The Equity News Report: A free bonus copy of their groundbreaking ebook “The Smart Investor’s Guide to Equity Market Trends” and their special report on a little known stock in the pharma industry called “The $5.7 Billion Kidney Disease Market Opportunity”
Take advantage of this opportunity today and
download all 3 for free! |
|
|
When the Fed Talks, Should You Listen? |
Remember the story about the boy who cried wolf? Well, there seems to be a Wall Street version. Investors are starting to wonder if all this hawkish Fed chatter is just noise. See, the market loves to get spooked about higher rates. Stocks shudder, investors sweat... but lately, those big rate hikes just haven't materialized.
It's like the market finally realized it doesn't have to jump just because someone says "boo!" This could mean those short-term dips are actually buying opportunities dressed up as scary headlines. Then again, maybe those Fed wolves are just gathering their strength, getting ready for a really big bite.
Did you know? In the 1970s, the stock market endured a decade-long slump despite low-interest rates. So, maybe the Fed isn't the only factor to watch... |
|
|
After a five-month slide, AMD just kissed its 1-day moving average (MA100) – a technical indicator that's got traders buzzing. Is this just a blip, or the start of a trend reversal? Let's unpack the clues: -
Déjà vu: AMD's recent 30% drop curiously mirrors a similar correction last year. Could history be repeating itself... this time with an upside?
- Double your chances: A two-part entry strategy might make sense here. Buy some now on the MA100 bounce, and add more if it dips to the MA200.
- The RSI Factor: Watch the Relative Strength Index (RSI). A rising support line there would confirm a potential bottom.
-
Target in sight: Our sights are set on $260, the 1.382 Fibonacci extension, which also marked a significant high last year.
Remember, charts paint a picture, but don't tell the whole story. AMD still faces industry-wide headwinds. But for those with an eye for patterns, this setup could be worth investigating. |
|
|
EDITOR’S NOTE: Our friends at The Freeport Society and Louis Navellier have just issued a shocking election prediction for 2024. Read on for the details… |
I believe Donald J. Trump will go down as America’s last Republican president. But NOT for the reasons you may think… Click here to see my 2024 election prediction.
If I’m right, the soul of this country will change forever… Louis Navellier Editor, InvestorPlace
|
|
|
Oversold...Eventually. But Patience is Key
|
We've talked short-term market fatigue – and rightfully so. But what about the bigger picture? Let's dive into the intermediate-term indicators.
Here's the thing: while some signals are flashing oversold, the math tells us this is no quick fix. The 30-day moving average of the advance/decline line just dipped below zero this week, suggesting a potential oversold condition... by early May. Similarly, the McClellan Summation Index keeps heading lower. This puppy usually needs to cross the zero line for a trend reversal.
Other indicators paint a similar story: - Volume Indicator: Currently at 50%, it typically needs to hit the 40s to signal a bottom.
- Hi-Lo Indicator: Eyes on the 0.15-0.20 range for a true oversold reading.
Sentiment, as always, tells a story. While slightly less complacent, real fear hasn't quite kicked in. We're likely to see surveys reflect the recent dip, but it may take another leg down for investors to truly get spooked. That second drop is often where sudden shifts happen. So, what's the takeaway? -
Patience, Trendsters: A brief rally followed by another leg down seems like the most probable scenario. Oversold conditions are brewing, but it'll take time to play out.
- Don't get complacent: Those short-term bounces can be tempting, but remember the bigger picture still has room to run.
- The silver lining: This extended correction creates long-term opportunities. If you've got the stomach for it, use those dips to cherry-pick undervalued stocks.
It's not a roller coaster market, it's more like a slow descent with the occasional sudden jerk. |
|
|
Earnings, Housing, and the Fed Factor
|
Here's a quick rundown of what's shaking up the market today: Earnings in the Spotlight Bank of America took a hit after reporting lower profit and revenue. Ouch!
Johnson & Johnson topped expectations, but still shed some points. Market jitters strike again. Live Nation facing heat as the DOJ reportedly plans an antitrust suit. Morgan Stanley, on the other hand, saw a boost thanks to strong results.
Earnings Season Ramps Up: A whole slew of major companies across various sectors will drop their reports this week. Eyes on ASML (semiconductors), Abbott Laboratories, Travelers, and more. Tech giants like Netflix join the party on Thursday. Stay tuned! Housing Data Disappoints Housing starts and building permits fell short of forecasts in March. This adds to the mixed picture of the economy. The Fed Dance Continues
Economic figures released Tuesday did little to sway expectations that the Fed isn't going to ease anytime soon. That June rate cut? Looking less and less likely by the day. Key Takeaways:
Earnings season is a key driver – watch out for surprises that could move individual stocks and broader sectors. Housing data reflects ongoing economic challenges, feeding into the overall rate debate. The Fed remains in focus: Don't expect them to give up the inflation fight just yet. |
|
|
MARKET MUSINGS & TIME CAPSULE |
Random Musings
Ever wonder how much different history would be if people checked their sources before retweeting (or the medieval equivalent)? Probably a lot less 'burning at the stake' and more reasoned discourse.
"Oversold" is a term tossed around a lot in markets. But how 'oversold' does a civilization need to be before they decide to, you know, stop with the whole Coliseum gladiator thing? Speaking of things that were once popular, then weren't... where did all those time machines go? Market's looking a bit wobbly, I could use a trip back to last month. Remember when 'influencer' meant someone whose ideas changed the world, not which smoothie to buy? Just me?
Markets are much like weather – prone to unexpected shifts, driven by complex forces, and best understood with the right tools... and maybe a raincoat. On this day in history, April 17 April 17, 1970: Apollo 13 returns safely to Earth after a harrowing mission. Proof that even when disaster strikes, quick thinking and a focus on fundamentals can bring you home.
April 17, 1961: The Bay of Pigs invasion. A reminder that even well-funded, meticulously planned ventures can fall prey to unforeseen circumstances. April 17, 1941: Yugoslavia surrenders to the Axis powers during World War II. Even in the face of overwhelming force, sometimes the most strategic move is to fight another day. April 17, 1790: Benjamin Franklin, legendary inventor, statesman, and founding father, passes away. An icon of American ingenuity and a keen observer of human nature (two traits handy in the markets!)
April 17, 1521: Martin Luther, the German monk who sparked the Protestant Reformation, is put on trial for his beliefs. Conviction and a willingness to challenge the status quo – sometimes that's what moves markets too. |
|
|
"There are two times in a man's life when he should not speculate: when he can't afford it and when he can." – Unknown
Okay Trendsters, before we sign off, a little nugget of wisdom from an unknown sage. Seems fitting for today's theme! Amid the market's ups and downs, remember that speculation has its place, but so does knowing when to play it safe.
Whether you're buying those dips or staying cautiously on the sidelines, the key is informed decision-making. Do your research, manage your risk, and remember: sometimes the most brilliant investment move is knowing when to wait it out. |
|
|
*** The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the "Services") is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by Universal Financial Independence Inc., ("Universal") a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk and is not appropriate for everyone. The actual profit results presented here may vary with the actual profit results presented in other Universal Financial Independence, Inc. publications due to the different strategies and time frames presented in other publications. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, Universal does not make any guarantee or other promise as to any results that may be obtained from using the Services. Universal disclaims any and all liability for any investment or trading loss sustained by a subscriber. You should trade or invest only "risk capital" - money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses.
Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Universal makes no representations or warranties that any account will or is likely to achieve profits similar to those shown. No representation is being made that you will achieve profits or the same results as any person providing a testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have subsequently experienced losses. Wendy Kirkland's experiences are not typical. Wendy Kirkland is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position, willingness to follow the rules and other factors.
|
|
|
Disclaimer: Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience.
This newsletter provides general information that does not take into account your objectives, financial situation or needs. The content of this newsletter or our website must not be construed as personal advice. COE Media is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor.
Any past performance presented is not necessarily indicative of future success.
Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
Advertising Disclosure: This email contains paid advertisements and we have been paid in some fashion to send this advertisment to our readers.
If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking on the unsubscribe link and you will no longer receive this email. If you have any questions, please send an email with your questions to [email protected]
We strongly urge you to read our full disclaimer here. UNSUBSCRIBE TradersOnTrend.com COE MEDIA. 1126 S Federal Hwy
Unit #827 Fort Lauderdale, FL 33316 |
|
|
|
